Phoenix Neurological Associates, Ltd.
5090 N. 40th Street
Suite 250
Phoenix, AZ 85018

Phone: (602) 258-3354
Fax: (602) 258-3368

email Phoenix Neurological Associates (If you have an urgent medical issue, do not email; please call us instead.)

news

Dr. Payne’s Team Saves Employee. Read more and watch the video

Phoenix Neurological Associates, LTD was just named one of seven international centers of Excellence for Guillan Barre and CIDP. Read more

BITE NITE 2010
Our first fundraiser took place on June 5, 2010 at Scottsdale Resort and Conference Center. PNA Center for Neurological Research teamed up with the ALS Association Arizona Chapter to co-host a night dedicated to ALS (Lou Gehrig’s Disease). BITE NITE consisted of 5 top Valley Restaurants, 5th and Wine, Cien Agaves Tacos & Tequila, Oregano's Pizza Bistro and Va Bene who served up samplers of their best dishes, with great entertainment by our favorite local band Dearspeak, with silent and live auctions. The night was an absolute blast and a success. People enjoyed great food while enjoying each other’s company for a night that was dedicated to funding ALS research. Thank you for everyone who truly made this night a success. Due to the positive praise and feedback, BITE NITE will be an annual event, so if you weren’t able to attend, we look forward to seeing you there next year! Thanks again for your support, dedication and contributions, we couldn’t have made this night possible without you.

Check out photos from BITE NITE here.

Share |


Publications By Our Physicians

ALS

A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.

Whole-genome analysis of sporadic amyotrophic lateral sclerosis.

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder.

CIDP

Chronic Inflammatory Demyelinating Polyneuropathy

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

Distal acquired demyelinating symmetric neuropathy.

IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab.

Treatment of IgM antibody associated polyneuropathies using rituximab.

Dermatomyositis

Rituximab in the treatment of dermatomyositis: an open-label pilot study.

History of dermatomyositis

Guillain Barre

Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy.

Inclusion Body Myositis

Pilot trial of etanercept in the treatment of inclusion-body myositis.

Muscular Dystrophy

Clinical and genetic aspects of distal myopathies.

Multiple Sclerosis

Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Myasthenia Gravis

Management of myasthenia gravis.

Peripheral Neuropathy

Peripheral neuropathy in an outpatient cohort of patients with Sjögren's syndrome.

Peripheral neuropathies in Waldenström's macroglobulinaemia.

Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Chronic acquired demyelinating polyneuropathies.

IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab.

Treatment of IgM antibody associated polyneuropathies using rituximab.

Peripheral Neuropathy Due to Cobalamin Deficiency

Challenges in the identification of cobalamin-deficiency polyneuropathy.

Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics.

Polymyositis

Inflammatory myopathy with cytochrome oxidase negative muscle fibers: methotrexate treatment.

Other

Muscle channelopathies.